Trilogy Metals shares soar nearly 200% in premarket after U.S. takes stake in minerals explorer

Trilogy Metals shares soar nearly 200% in premarket after U.S. takes stake in minerals explorer


US President Donald Trump, left, and Doug Burgum, US secretary of the interior, in the Oval Office of the White House in Washington, DC, US, on Monday, Oct. 6, 2025.

Bloomberg | Bloomberg | Getty Images

Shares of U.S.-listed minerals explorer Trilogy Metals jumped as much as 205% in premarket trade on Tuesday, shortly after the White House said it would take a 10% stake in the Canadian company.

The stock was seen trading 183% higher in premarket deals at 9:54 a.m. London time (4:54 a.m. ET).

The White House on Monday announced a partnership with Trilogy Metals as part of a push to unlock domestic supplies of copper and other critical minerals in the Ambler mining district in Alaska.

The partnership included a $35.6 million investment, which makes the U.S. government a 10% shareholder in Trilogy Metals.

Trilogy Metals welcomed Trump’s decision to grant permits to enable the development of critical minerals in Alaska, saying the Ambler mining district is “home to some of the world’s richest known copper-dominant polymetallic deposits.”

The company said in a statement that Trump’s order, which reverses the Biden administration’s rejection of the Ambler Road project, “reflects a renewed federal commitment to responsible resource development in Alaska and highlights the Ambler Road as critical infrastructure under federal policy.”

It added that the move would help to secure domestic supply chains for minerals including copper, cobalt, zinc and lead, highlighting the importance of these resources in energy infrastructure, defense technologies and manufacturing.



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More